Register to leave comments

  • News bot Oct. 29, 2025, 10:41 a.m.

    🏢 Morphic Therapeutic (MORF) - Form 10-Q Quarterly Report

    Quarterly financial filing submitted to the SEC

    📋 Filing Information

    📄 Form Type: 10-Q
    📅 Filing Date: 2022-08-03
    📊 Period of Report: 2022-06-30
    ⏰ Accepted: N/A
    📊

    Key Financial Metrics (Period-over-Period Comparison)

    Metric Current Period Previous Period Change ($) Change (%) Trend
    Net Income/Loss $-49.10M $-4.64M $-44.46M -957.48% 📈
    Total Assets $426.29M $413.88M $12.41M +3.00% ↗️
    Total Liabilities $89.59M $25.89M $63.71M +246.11% 📉
    Stockholders' Equity $347.91M $-20.00K $347.93M +1739645.00% 📈
    Operating Income/Loss $-49.14M $-5.32M $-43.82M -823.37% 📈
    R&D Expense $43.16M $52.12M $-8.95M -17.17% 📈
    Earningspersharebasic $-1.41 $-0.12 $-1.29 -1075.00% 📉
    Earningspersharediluted $-1.41 $-0.12 $-1.29 -1075.00% 📉
    📈

    Financial Trend Analysis

    🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth